Published in Cancer Lett on August 20, 2004
BCL2A1: the underdog in the BCL2 family. Cell Death Differ (2011) 1.56
Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer. Oncotarget (2016) 1.44
Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia. Br J Cancer (2007) 1.05
Inflammatory pathways as promising targets to increase chemotherapy response in bladder cancer. Mediators Inflamm (2012) 0.91
Silodosin inhibits the growth of bladder cancer cells and enhances the cytotoxic activity of cisplatin via ELK1 inactivation. Am J Cancer Res (2015) 0.83
The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1. Mol Cancer (2011) 0.79
Cisplatin inhibits hippocampal cell proliferation and alters the expression of apoptotic genes. Neurotox Res (2013) 0.79
Upregulated expression of BCL2, MCM7, and CCNE1 indicate cisplatin-resistance in the set of two human bladder cancer cell lines: T24 cisplatin sensitive and T24R2 cisplatin resistant bladder cancer cell lines. Investig Clin Urol (2016) 0.78
Nuclear Factor-kappa B as a Resistance Factor to Platinum-Based Antineoplasic Drugs. Met Based Drugs (2008) 0.78
TRIM29 Overexpression Promotes Proliferation and Survival of Bladder Cancer Cells through NF-κB Signaling. Cancer Res Treat (2016) 0.75
Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial. J Clin Oncol (2010) 13.03
Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell (2007) 6.55
Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity (2009) 3.91
A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety update. Eur J Cancer (2013) 2.51
The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins. Cancer Lett (2004) 2.00
Rising prostate cancer rates in South Korea. Prostate (2006) 1.83
Crystal structure of CD14 and its implications for lipopolysaccharide signaling. J Biol Chem (2005) 1.70
Nomograms to predict the pathological stage of clinically localized prostate cancer in Korean men: comparison with western predictive tools using decision curve analysis. Int J Urol (2012) 1.58
Prognostic factors for chronic kidney disease after curative surgery in patients with small renal tumors. Urology (2009) 1.55
Prostate cancer in Korean men exhibits poor differentiation and is adversely related to prognosis after radical prostatectomy. Urology (2006) 1.47
Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis. Cancer Res (2008) 1.45
Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination. Cancer Res (2007) 1.43
The anti-aging gene KLOTHO is a novel target for epigenetic silencing in human cervical carcinoma. Mol Cancer (2010) 1.39
Hyper innate responses in neonates lead to increased morbidity and mortality after infection. Proc Natl Acad Sci U S A (2008) 1.33
Expression of NDRG2 is related to tumor progression and survival of gastric cancer patients through Fas-mediated cell death. Exp Mol Med (2007) 1.24
Expression and regulation of NDRG2 (N-myc downstream regulated gene 2) during the differentiation of dendritic cells. FEBS Lett (2003) 1.23
Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells. Carcinogenesis (2009) 1.21
Collagen triple helix repeat containing 1 (CTHRC1) acts via ERK-dependent induction of MMP9 to promote invasion of colorectal cancer cells. Oncotarget (2014) 1.20
A novel adipokine CTRP1 stimulates aldosterone production. FASEB J (2008) 1.20
NDRG2 suppresses cell proliferation through down-regulation of AP-1 activity in human colon carcinoma cells. Int J Cancer (2009) 1.18
Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression. Biochem Pharmacol (2011) 1.17
Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation. Cancer Res (2009) 1.15
Regulation of BNIP3 in normal and cancer cells. Mol Cells (2006) 1.14
Evaluation of annexin II as a potential serum marker for hepatocellular carcinoma using a developed sandwich ELISA method. Int J Mol Med (2009) 1.13
Bone morphogenetic protein-4 induced by NDRG2 expression inhibits MMP-9 activity in breast cancer cells. Biochem Biophys Res Commun (2009) 1.12
SOCS1 induced by NDRG2 expression negatively regulates STAT3 activation in breast cancer cells. Biochem Biophys Res Commun (2007) 1.11
Stimulating lymphotoxin beta receptor on the dendritic cells is critical for their homeostasis and expansion. J Immunol (2005) 1.10
DNA gyrase is involved in chloroplast nucleoid partitioning. Plant Cell (2004) 1.09
Expression of survivin in renal cell carcinomas: association with pathologic features and clinical outcome. Urology (2007) 1.09
Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1. Oncogene (2004) 1.08
Up-regulation of Mac-2 binding protein by hTERT in gastric cancer. Int J Cancer (2007) 1.08
dSETDB1 and SU(VAR)3-9 sequentially function during germline-stem cell differentiation in Drosophila melanogaster. PLoS One (2008) 1.08
Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer. J Urol (2004) 1.07
Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders. PPAR Res (2008) 1.07
Adiponectin is a negative regulator of NK cell cytotoxicity. J Immunol (2006) 1.06
Prognostic significance of the nadir prostate specific antigen level after hormone therapy for prostate cancer. J Urol (2002) 1.06
Activation of Ras up-regulates pro-apoptotic BNIP3 in nitric oxide-induced cell death. J Biol Chem (2006) 1.06
Apolipoprotein A-I induces IL-10 and PGE2 production in human monocytes and inhibits dendritic cell differentiation and maturation. Biochem Biophys Res Commun (2005) 1.04
A proinflammatory cytokine interleukin-32beta promotes the production of an anti-inflammatory cytokine interleukin-10. Immunology (2008) 1.03
Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells. Cancer Lett (2005) 1.03
Recent changes in the clinicopathologic features of Korean men with prostate cancer: a comparison with Western populations. Yonsei Med J (2012) 1.02
Progressive neuronal loss and behavioral impairments of transgenic C57BL/6 inbred mice expressing the carboxy terminus of amyloid precursor protein. Neurobiol Dis (2005) 1.01
ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma. Amino Acids (2010) 1.00
Crystal structure of the BAFF-BAFF-R complex and its implications for receptor activation. Nat Struct Biol (2003) 0.99
Effect of subclinical prostatic inflammation on serum PSA levels in men with clinically undetectable prostate cancer. Urology (2003) 0.99
Increase in CIP2A expression is associated with doxorubicin resistance. FEBS Lett (2011) 0.99
ESM-1 regulates cell growth and metastatic process through activation of NF-κB in colorectal cancer. Cell Signal (2012) 0.99
Accuracy of bladder volume determinations by ultrasonography: are they accurate over entire bladder volume range? Urology (2003) 0.98
Perineural invasion is a prognostic factor for biochemical failure after radical prostatectomy. Int J Urol (2009) 0.98
Augmentation of cisplatin sensitivity in cisplatin-resistant human bladder cancer cells by modulating glutathione concentrations and glutathione-related enzyme activities. BJU Int (2005) 0.98
Upregulation of the cysteine protease inhibitor, cystatin SN, contributes to cell proliferation and cathepsin inhibition in gastric cancer. Clin Chim Acta (2009) 0.98
Upregulation of the cycline kinase subunit CKS2 increases cell proliferation rate in gastric cancer. J Cancer Res Clin Oncol (2008) 0.98
Identification of endothelial cell-specific molecule-1 as a potential serum marker for colorectal cancer. Cancer Sci (2010) 0.97
Osteoporosis regulation by salubrinal through eIF2α mediated differentiation of osteoclast and osteoblast. Cell Signal (2012) 0.97
Cyclooxygenase-2-dependent neuronal death proceeds via superoxide anion generation. Free Radic Biol Med (2006) 0.97
Serum starvation induces G1 arrest through suppression of Skp2-CDK2 and CDK4 in SK-OV-3 cells. Int J Oncol (2008) 0.96
Up-regulation and clinical significance of serine protease kallikrein 6 in colon cancer. Cancer (2010) 0.96
SUMOylation of RORalpha potentiates transcriptional activation function. Biochem Biophys Res Commun (2008) 0.96
Gender-specific clinicopathological features and survival in patients with renal cell carcinoma (RCC). BJU Int (2011) 0.96
Protein profiling and identification of modulators regulated by the E7 oncogene in the C33A cell line by proteomics and genomics. Proteomics (2004) 0.95
Production of antibodies with peptide-CpG-DNA-liposome complex without carriers. BMC Immunol (2011) 0.95
T lymphocytes and dendritic cells are activated by the deletion of peroxiredoxin II (Prx II) gene. Immunol Lett (2005) 0.94
Crystallographic and mutational analysis of the CD40-CD154 complex and its implications for receptor activation. J Biol Chem (2011) 0.94
Rational biosynthetic engineering for optimization of geldanamycin analogues. Chembiochem (2009) 0.94
Prevention and therapy of hepatocellular carcinoma by vaccination with TM4SF5 epitope-CpG-DNA-liposome complex without carriers. PLoS One (2012) 0.94
Dysregulation of overexpressed IL-32α in hepatocellular carcinoma suppresses cell growth and induces apoptosis through inactivation of NF-κB and Bcl-2. Cancer Lett (2011) 0.93
Inactivation of the carbamoyltransferase gene refines post-polyketide synthase modification steps in the biosynthesis of the antitumor agent geldanamycin. J Am Chem Soc (2004) 0.93
Tumor necrosis factor-alpha and interleukin-1beta increases CTRP1 expression in adipose tissue. FEBS Lett (2006) 0.93
ATM blocks tunicamycin-induced endoplasmic reticulum stress. FEBS Lett (2009) 0.93
Collagen triple helix repeat containing-1 (CTHRC1) expression in invasive ductal carcinoma of the breast: the impact on prognosis and correlation to clinicopathologic features. Pathol Oncol Res (2013) 0.93
Inhibitory effect of jaceosidin isolated from Artemisiaargyi on the function of E6 and E7 oncoproteins of HPV 16. J Ethnopharmacol (2005) 0.93
RhoGDI2 promotes epithelial-mesenchymal transition via induction of Snail in gastric cancer cells. Oncotarget (2014) 0.93
Nitric oxide induces BNIP3 expression that causes cell death in macrophages. Biochem Biophys Res Commun (2004) 0.92
Aberrant up-regulation of LAMB3 and LAMC2 by promoter demethylation in gastric cancer. Biochem Biophys Res Commun (2011) 0.92
Enhanced antitumor activity of vitamin C via p53 in cancer cells. Free Radic Biol Med (2012) 0.91